Mei Zhang

Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin‐naive individuals with type 2 diabetes mellitus

D. Owens, B. Frier, G. Bolli, 2018, Diabetes, obesity & metabolism.

β-cell function and insulin sensitivity contributions on incident diabetes in patients with endogenous Cushing's syndrome.

Lin Jiang, D. Cui, Yucheng Wang, 2022, Diabetes research and clinical practice.

Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL

D. Owens, B. Frier, G. Bolli, 2019, Diabetes, obesity & metabolism.

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%

D. Owens, B. Frier, P. Home, 2019, Diabetes, obesity & metabolism.

Association between systemic iron status and β-cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes

Yiting Huang, L. Qin, Yuxiao Li, 2023, Frontiers in Endocrinology.